Lunate Holding RSC Ltd — Q4 2024 13F-HR

← Lunate Holding RSC Ltd

Q4 2024 · 13F-HR

Lunate Holding RSC Ltdholdings as filed

Filed 2025-02-14 · accession 0001011438-25-000154

$210.9M

Reported value

Positions

2024-12-31

Period end

View analyzed profile →PRO

Holdings as filed

CUSIP	Ticker	Issuer	Value	% port.	Shares	Class	Voting
76155X100	RVMD	REVOLUTION MEDICINES INC	$96.1M	45.5%	2,196,200	Common	SOLE
M2029K104	BIRK	BIRKENSTOCK HOLDING PLC	$57.2M	27.1%	1,010,000	Common	SOLE
53566V106	LINE	LINEAGE INC	$35.1M	16.7%	600,000	Common	SOLE
640979100	NMRA	NEUMORA THERAPEUTICS INC.	$22.5M	10.7%	2,124,143	Common	SOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.